Pharmafile Logo
Pharmafocus logo
Advanced Search
BMS image

BMS abandons hep C, diabetes and neuroscience

November 11, 2013
Sales and Marketing BMS, HIV, diabetes, hep C

Bristol-Myers Squibb is admitting defeat in hepatitis C, diabetes and neuroscience and will abandon research in these areas in a …

News
Eylea image

Bayer submits Eylea in EU for DME

November 8, 2013
Sales and Marketing Bayer, DME, EMA, Eylea, FDA

Bayer HealthCare is seeking to extend the licence of its VEGF Trap-Eye, which is already marketed as Eylea in various …

News
brilinta image

EMA questions Brilinta data

November 8, 2013
Sales and Marketing Brilinta, EMA, astrazenca, heart, ticagrelor

The European Medicines Agency is demanding more information from AstraZeneca on its troubled heart pill Brilinta. This rounds off a …

News
gerald_moller

Genticel appoints vice president



November 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genticel, moeller

Biopharma firm Genticel has appointed Dr Gerald Moeller to sit on its supervisory Board as a vice president. Moeller has …

Appointment
dna image

UK to launch DNA database

November 8, 2013
Sales and Marketing DNA, UK, crispr, genome

Volunteers prepared to share their DNA with the rest of the world are being sought by scientists in the UK, …

News

Alzheimer’s drug development ‘must speed up’

November 7, 2013
Research and Development, Sales and Marketing Alzheimer's, CEO, drug development

Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …

News
shire image

Shire to cut UK research jobs says source

November 7, 2013
Research and Development, Sales and Marketing England, Shire, UK, cuts

Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …

News
NHS image

PPRS: thumbs-down from pharma

November 7, 2013
Sales and Marketing ABPI, NHS, PPRS, Pfizer, VBP

A missed opportunity for patients, which creates financial problems for smaller companies while stifling life science investment – these are …

News

Biotec Services expands with new appointments

November 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotec services

Clinical trials services firm Biotec Services International is expanding its presence in the US and the UK with three new …

Appointment

£10 million boost for synthetic biology

November 6, 2013
Research and Development, Sales and Marketing Biological, Synthetic, biotech

The Biotechnology and Biological Science Research Council (BBSRC) has put up £10 million which can be accessed by small companies …

News
Deepak Khanna image

PPRS to remain in UK, but drug growth curbed

November 6, 2013
Sales and Marketing ABPI, DH, Deepak Khanna, NHS, PPRS

The UK government has announced that the PPRS pricing scheme will largely remain intact, but will have a curb put …

News
Adheris image

inVentiv Health acquires Catalina Health

November 6, 2013
Medical Communications Adheris, catalina, inVentiv Health

Consulting and services company inVentiv Health has acquired a subsidiary of Catalina (Catalina Health) and joined it onto its own …

News
Roche image

ImmunoGen stops cancer trial

November 6, 2013
Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche

Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …

News
dan_bradbury

Profil Institute hires former Amylin chief executive

November 6, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amylin, profil institute

Clinical research firm Profil Institute has appointed former Amylin chief executive Dan Bradbury to its Board of directors.  “Dan Bradbury …

Appointment
ABPI reception

VBP diluted, NHS drugs bill to be reduced

November 5, 2013
Medical Communications, Research and Development, Sales and Marketing Horsham, PPRS, VBP

News
novartis_st_johann_night

Nearly 400 jobs to go at UK Novartis site

November 5, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, Sandwich

News
BIA image

UK is the go-to place for developing medicines

November 5, 2013
Research and Development, Sales and Marketing BIA, Cell Medica, ReNeuron, UK

The BioIndustry Association (BIA) has said that the UK is clearly the must-go-to location for regenerative medicine research and development. …

News
J&J image

J&J hit with $2.2 billion fine

November 5, 2013
Sales and Marketing J&J, JJ, Janssen, Risperdal, antipsychotic, fine

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …

News
BMS image

BMS files oral hep C treatment

November 5, 2013
Sales and Marketing BMS, HCV, dvc, hep C

Bristol-Myers Squibb has filed its investigational hepatitis C treatment – the first oral regime without interferon or ribavirin – with …

News
jeff_winton_astellas

Astellas poaches comms head from Lilly

November 5, 2013

Astellas has hired Jeffrey Winton from Eli Lilly to be its senior vice president and chief communications officer.Winton who will …

Appointment
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026